Stay updated on DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Sign up to get notified when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:25:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-15T19:37:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:28:36.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the study protocol (v2.15.0) and includes the addition of collaborators, while significant details about the study's methodology and eligibility criteria have been removed.
    Difference
    51%
    Check dated 2025-04-16T14:37:28.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:48:48.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:32:17.000Z thumbnail image

Stay in the know with updates to DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DPX-Survivac & Checkpoint Inhibitor in DLBCL Clinical Trial page.